"10.1371_journal.pone.0117560","plos one","2015-02-18T00:00:00Z","Ying Li; Xiao-hui Li; Zhi-jun Huang; Guo-ping Yang; Guo-gang Zhang; Shui-ping Zhao; Ying Guo; Shi-juan Lu; Jian-lin Ma; Fan-bo Meng; Ping Chen; Hong Yuan","Center of Clinical Pharmacology, the Third Xiangya hospital, Central South University, Changsha, China; Department of Pharmacology, School of Pharmaceutical Sciences, Central South University, Changsha, China; Department of Cardiovascular Medicine, Xiangya Hospital, Central South University, Changsha, China; Department of Cardiology, the Second Xiangya Hospital, Central South University, Changsha, China; Department of Cardiology, Hunan Provincial People’s Hospital, Changsha, China; Department of Cardiology, Haikou City People’s Hospital, Haikou, China; Department of Cardiology, Hainan Provincial People’s Hospital, Haikou, China; Department of Cardiology, China Japan Union Hospital of Jilin University, Changchun, China; Department of Cardiology, Shantou Central Hospital, Shantou, China","Conceived and designed the experiments: GGZ SPZ YG SJL JLM FBM PC HY. Performed the experiments: YL XHL GPY ZJH. Wrote the paper: YL XHL.","The authors have the following interests. This Trial is funded by Shenzhen Salubris Pharmaceuticals Co.,Ltd. All clinical investigators received support budgets from Shenzhen Salubris Pharmaceuticals Co., Ltd for the conduct of the clinical trial. Hangzhou Tigermed Co. Ltd is independently in charge of data collection and statistical analysis. The drug used in this study, Allisartan Isoproxil, was developed by Shenzhen Salubris Pharmaceuticals Co.,Ltd and Shanghai ALLIST Medicine Technology Co., Ltd. The authors understand that recently, the ownership of Allisartan Isoproxil was transferred to Shenzhen Salubris Pharmaceuticals Co.,Ltd on Oct 24, 2013. There are no further patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2015","02","Ying Li","YL",12,TRUE,8,4,NA,2,TRUE,FALSE,FALSE,0,NA,FALSE
